v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 113,209 $ 200,404
Short-term investments 244,036 300,255
Restricted cash - short-term 194 194
Accounts receivable   1,250
Prepaid expenses and other current assets 12,058 21,170
Total current assets 369,497 523,273
Property and equipment, net 53,485 50,517
Operating lease assets, net 25,071 12,303
Restricted cash - long-term 1,200 1,200
Other assets 670 827
Total assets 449,923 588,120
Current liabilities:    
Accounts payable 16,543 7,118
Accrued compensation 19,140 20,458
Accrued research and development expenses 9,974 15,813
Deferred revenue 31,226 33,455
Other current liabilities 9,267 6,057
Total current liabilities 86,150 82,901
Deferred revenue - long-term 26,843 27,795
Operating lease liabilities - long-term 24,574 13,041
Other long-term liabilities 2,215 2,044
Total liabilities 139,782 125,781
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of September 30, 2021 and December 31, 2020; 88,387 and 83,372 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 9 8
Additional paid-in capital 1,681,481 1,586,616
Accumulated other comprehensive income 24 296
Accumulated deficit (1,371,373) (1,124,581)
Total stockholders’ equity 310,141 462,339
Total liabilities and stockholders’ equity $ 449,923 $ 588,120

Source